279 POSTER MLN8054, a selective inhibitor of Aurora A kinase: final results of a phase I clinical trial

Autor:	Teresa Macarulla, José Baselga, E. Rodriguez-Braun, A. Chakravarty, J. Tabernero, A. Cervantes, Omar Eton, Susana Roselló, D. Bowman, H. Liu
Rok vydání:	2008
Předmět:	Cancer Research Oncology business.industry Cancer research Aurora A kinase Phases of clinical research Medicine business
Zdroj:	European Journal of Cancer Supplements. 6:90
ISSN:	1359-6349
DOI:	10.1016/s1359-6349(08)72213-4
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::027f77ddb170d9f6e5c19e25fd3bc8f3 https://doi.org/10.1016/s1359-6349(08)72213-4 Zobrazit plný text záznamu Full Text from ScienceDirect